Cite
HARVARD Citation
Provencio, M. et al. (2021). Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment. European journal of cancer. pp. 61-72. [Online].